IMMUSOFT

Once we have programmed the B cells we expand the number and differentiate into plasma cells that produce massive amounts of our therapeutic protein. Once in the clinic, we will then infuse the ISP™ programmed cells back into the same patient, where we expect they will take up residence and produce therapeutic proteins for extended periods of time... This chart provides an overview of our ground breaking technology. Click below for a fuller explanation.

Also known as: Immusoft of CA, Inc.

Primary location: Seattle United States